文献速递白血病淋巴瘤

携带TLX3::BCL11B并伴TLX3激活的T/髓系混合表型急性白血病

T/myeloid mixed phenotype acute leukaemia harbouring TLX3::BCL11B with TLX3 activation.
PubMed 文献 · Br J Haematol · 2024-02-22

本文报告两例携带BCL11B相关结构变异并激活TLX3的T/髓系混合表型急性白血病(MPAL)年轻男性患者,均有髓外受累。全基因组测序和转录组分析检测到T/髓系MPAL和T淋巴母细胞白血病(T-ALL)特征性的协同基因改变。两例均经谱系匹配的ALL方案获初始缓解,其中一例需转换为髓系方案。

要点

  • 两例年轻男性T/髓系MPAL患者均携带TLX3::BCL11B并伴TLX3激活。
  • 两例均检测到T/髓系MPAL和T-ALL特征性的协同基因改变。
  • 两例经谱系匹配的ALL方案获初始缓解,一例需转为髓系方案。

核心结论

  • 本研究首次揭示TLX3::BCL11B-TLX3激活的T/髓系MPAL的临床病理和基因组特征,并为白血病发生机制提供见解。

研究设计与样本

  • 两例T/髓系MPAL病例报告,采用全基因组测序和转录组分析。

主要发现

  • 两例均为年轻男性,伴髓外受累。
  • 两例均检测到BCL11B相关结构变异激活TLX3(TLX3::BCL11B-TLX3激活)。
  • 两例均检测到T/髓系MPAL和T-ALL特征性的协同基因改变。
  • 两例均经谱系匹配的ALL方案获初始缓解,其中一例需转换为髓系方案。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

T/myeloid mixed phenotype acute leukaemia (MPAL) is a rare aggressive acute leukaemia with poorly understood pathogenesis. Herein, we report two cases of T/myeloid MPAL harbouring BCL11B-associated structural variants that activate TLX3 (TLX3::BCL11B-TLX3-activation) by genome sequencing and transcriptomic analyses. Both patients were young males with extramedullary involvement. Cooperative gene alterations characteristic of T/myeloid MPAL and T-lymphoblastic leukaemia (T-ALL) were detected. Both patients achieved initial remission following lineage-matched ALL-based therapy with one patient requiring a lineage-switched myeloid-based therapy. Our study is the first to demonstrate the clinicopathological and genomic features of TLX3::BCL11B-TLX3-activated T/myeloid MPAL and provide insights into leukaemogenesis.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Botten GA, Zhang Y, Fuda F, et al. T/myeloid mixed phenotype acute leukaemia harbouring TLX3::BCL11B with TLX3 activation. Br J Haematol. 2024. PMID: 38385580. doi:10.1111/bjh.19363

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。